Long Term Safety Of GW685698X Via Nasal Biopsy

Clinical trial NCT00224523 · COMPLETED

Trial details

NCT number: NCT00224523
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rhinitis, Allergic, Perennial

Start date: 2005-09-01
Primary completion: 2007-02-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.